炎症
髓样
泡沫电池
单核细胞增多
单核细胞
先天免疫系统
免疫学
细胞因子
血脂异常
促炎细胞因子
免疫系统
特雷姆2
巨噬细胞
细胞生物学
生物
癌症研究
医学
脂蛋白
胆固醇
髓系细胞
内科学
疾病
内分泌学
体外
生物化学
骨髓
作者
Daniel Zysset,Benjamin Weber,Silvia Rihs,Jennifer Brasseit,Stefan Freigang,Carsten Riether,Yara Banz,Adelheid Cerwenka,Cédric Simillion,Pedro Manuel Marques-Vidal,Adrian F. Ochsenbein,Leslie Saurer,Christoph Mueller
摘要
Abstract Triggering receptor expressed on myeloid cells-1 (TREM-1) is a potent amplifier of pro-inflammatory innate immune responses, but its significance in non-infectious diseases remains unclear. Here, we demonstrate that TREM-1 promotes cardiovascular disease by exacerbating atherosclerosis. TREM-1 is expressed in advanced human atheromas and is highly upregulated under dyslipidemic conditions on circulating and on lesion-infiltrating myeloid cells in the Apoe−/− mouse model. TREM-1 strongly contributes to high-fat, high-cholesterol diet (HFCD)-induced monocytosis and synergizes with HFCD serum-derived factors to promote pro-inflammatory cytokine responses and foam cell formation of human monocyte/macrophages. Trem1−/−Apoe−/− mice exhibit substantially attenuated diet-induced atherogenesis. In particular, our results identify skewed monocyte differentiation and enhanced lipid accumulation as novel mechanisms through which TREM-1 can promote atherosclerosis. Collectively, our findings illustrate that dyslipidemia induces TREM-1 surface expression on myeloid cells and subsequently synergizes with TREM-1 to enhance monopoiesis, pro-atherogenic cytokine production and foam cell formation.
科研通智能强力驱动
Strongly Powered by AbleSci AI